From the Editor

Apr 01, 2001
Pharmaceutical Executive
Patents before profits. That soundbite snagged my ears and turned my full attention to the CNN business report. I recognized the voice and the face}Ray Gilmartin, chairman of Merck. Calmly and reasonably, he explained how extraordinary circumstances in the developing world demand that his company uncouple the normally fused objectives of high profitability and unwavering patent protection.
Mar 01, 2001
Pharmaceutical Executive
}Drug costs continue to rise at an alarming rate. Two major reasons for the increasing costs are introductions of new drugs and direct-to-consumer advertising campaigns that have been effective in marketing expensive name brand drugs.}
Feb 01, 2001
Pharmaceutical Executive
Managing expectations is the new alchemy. All manipulators of opinion, from the US president down to the humblest peddler, now seek to minimize what people expect
Jan 01, 2001
Pharmaceutical Executive
My parents recently showed me an old news photo of my brother being moved from one hospital to another, in his iron lung. The year was 1950. Just seven years old, visibly smiling as usual in his overhead mirror, Gary lay prone as a small crowd of medics guided the huge wheeled cylinder toward a waiting ambulance. Polio had widely destroyed the motor neurons in his brain and spinal cord, and his muscles had atrophied from lying still. The iron lung pushed and pulled his chest through the breathing cycle. Gary lived only a few months after the photo's dateline.
Jan 01, 2001
Pharmaceutical Executive
By Pharmaceutical Executive Editors
When Harry Schwartz joined Pharmaceutical Executive for its inaugural issue in January 1981, he had already written 19 books and was well-known for his medical-related writings in the New York Times and other publications. Every month since then, without fail, he has faithfully supplied his At Large column, with its far-ranging analysis and commentary on political and business trends that affect the industry. Every magazine changes over time, and now a series of changes has brought an end to that distinguished, 20-year-long contribution.
native1_300x100
lorem ipsum